13/11/2024  19:35:12 Chg. -0.620 Volume Bid20:49:57 Ask20:49:57 Market Capitalization Dividend Y. P/E Ratio
34.820EUR -1.75% 0
Turnover: 0.000
34.300Bid Size: 500 35.220Ask Size: 500 7.63 bill.EUR - -

Business description

Demant is a world-leading hearing healthcare and technology group built on a heritage of care, health and innovation since 1904. The Group offers innovative technologies, solutions and know-how to help improve people’s health and hearing. In every aspect, from hearing care, hearing aids and hearing implants to diagnostic equipment and services and audio solutions, Demant is active and engaged. Headquartered in Denmark, the Group employs approx. 16,500 people globally and is present with solutions in 130 countries where we create life-changing hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen as a blue chip stock.
 

Management board & Supervisory board

CEO
Søren Nielsen
Management board
René Schneider, Niels Wagner
Supervisory board
Niels B. Christiansen, Niels Jacobsen, Thomas Duer, Charlotte Hedegaard, Heidir Hørby, Sisse Fjelsted Rasmussen, Kristian Villumsen
 

Company data

Name: Demant A/S
Address: Kongebakken 9,DK-2765 Smørum
Phone: +45-3917-7300
Fax: +45-3927-7900
E-mail: info@demant.com
Internet: www.demant.com/
Industry: Industry
Sector: Mechanical Engineering
Sub sector: -
End of financial year: 31/12
Free Float: 39.27%
IPO date: -

Investor relations

Name: Peter Pudselykke
IR phone: +45-3917-7300
IR Fax: -
IR e-mail: pepu@demant.com

Main Shareholders

The William Demant Foundation
 
58.00%
Others
 
42.00%